Key result
Psychotropic medications further increase the already elevated risk of cardiovascular disease and premature mortality in people with serious mental illness, necessitating routine cardiometabolic monitoring.
Why the study?
Cardiovascular disease risk is higher in people with serious mental illness and is further increased in those taking psychotropic medication.
Does psychotropic medication increase the risk of cardiovascular disease in people with serious mental illness?
Does psychotropic medication increase the risk of cardiovascular disease in people with serious mental illness?
Psychotropic medications significantly increase the risk of cardiovascular disease and metabolic syndrome in patients with serious mental illness, highlighting the critical need for routine physical health screening and monitoring.
Supports cardiometabolic monitoring in SMI on psychotropics; leaves open precise attribution in prospective studies.
In people with serious mental illness, mortality and morbidity are significantly increased compared to the general population. This is often as a result of physical health problems; about two-thirds of premature death in people with serious mental illness has been attributed to natural causes including cardiovascular disease and diabetes. Cardiovascular disease risk in people with serious mental illness is higher than the general population, this risk is further increased in those with serious mental illness taking psychotropic medication. In this article, cardiovascular disease risk in serious mental illness, particularly the association with psychotropic interventions and monitoring required, is examined.
No takes yet. Share an insight, caveat, or question.
Mwebe et al. (2019) conducted a review in Serious mental illness. Psychotropic medication vs. General population or unexposed individuals was evaluated on Cardiovascular disease risk. Psychotropic medications further increase the already elevated risk of cardiovascular disease and premature mortality in people with serious mental illness, necessitating routine cardiometabolic monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: